Corticospinal propagation of full-length TDP-43 toxicity drives brain-to-muscle pathology
Jacopo Marongiu, V. CrippaiD, Isabella Marzi, Clara PorceddaiD, Maria Cristina GaglianiiD, Annalisa Brivio, Maria Francesca PalmasiD, Michela Etzi, Marcello SerraiD, Khosro Aminzadeh, Maria Antonietta CasuiD, Ignazia MocciiD, Augusta PisanuiD, Nicola SimolaiD, Valeria SogosiD, Raffaella IsolaiD, Maria Francesca ManchinuiD, Katia CorteseiD, Alfonso De SimoneiD, Fabrizio ChitiiD, Anna Rosa CartaiD
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive degeneration of upper and lower motor neurons. Cytoplasmic inclusions containing TAR DNA-binding protein 43 (TDP-43), a key regulator of RNA metabolism, represent a pathological hallmark of all sporadic (sALS) and most familial (fALS) forms, underscoring its central role in disease pathophysiology. In affected neurons, full-length (FL) TDP-43 undergoes nuclear-to-cytoplasmic mislocalization, leading to aggregation and cellular dysfunction, and can be released to propagate pathology across neural and non-neural circuits. However, the in vivo toxicity and spreading capacity of FL TDP-43 remain poorly defined. Here, we show that purified, stable human FL TDP-43 was readily internalized by neuronal cells, where it induced aggregation and significantly reduced cell viability. In vivo, an acute unilateral stereotaxic infusion of FL TDP-43 into the rat primary motor cortex was sufficient to trigger a robust centrifugal propagation of pathology along the corticospinal axis and beyond the central nervous system (CNS). TDP-43 pathology spread from the motor cortex to the spinal cord and reached skeletal muscle. At the cellular level, propagated pathology was characterized by intraneuronal phosphorylated TDP-43 (pTDP-43) inclusions, accumulation of high-molecular-weight TDP-43 species, region-specific neurodegeneration, and pronounced mitochondrial vulnerability. Notably, skeletal muscle displayed impaired mitochondrial bioenergetics, accompanied by both motor and non-motor behavioral deficits. Collectively, our findings demonstrate neuron-to-neuron, brain-to-spinal cord and brain-to-muscle spreading of FL TDP-43 toxicity in vivo, establishing a mechanistic link between central TDP-43 pathology and peripheral dysfunction. This work identifies FL TDP-43 as an active driver of disease spreading in ALS and provides the basis for a non-transgenic, TDP-43-driven rat model of disease propagation.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Amyotrophic lateral sclerosis associated mislocalisation of TDP-43 to the cytoplasm causes cortical hyperexcitability and reduced excitatory neurotransmission in the motor cortex.
Marcus S. Dyer, Laura A. Reale, … Catherine A. Blizzard·Journal of NeurochemistryPeer-reviewed·Oct 16, 2020
- Mislocalisation of TDP-43 to the cytoplasm of either neurons or oligodendrocytes causes axonopathy and dysmyelination
Marcus Keatinge, Sandra Constantinou Juhasz, … Siddharthan Chandran·bioRxiv·Nov 17, 2025
- Spinal cord extracts from sporadic ALS induce and propagate TDP-43 pathology in cerebral organoids
Yoshitaka Tamaki, Jay P. Ross, … Guy Armand Rouleau·PLoS GeneticsPeer-reviewed·Feb 6, 2023
- Low-level overexpression of wild type TDP-43 causes late-onset, progressive neurodegeneration and paralysis in mice
Chunxing Yang, Tao Qiao, … Zuoshang Xu·PLoS ONEPeer-reviewed·Feb 3, 2022
- Shortened TDP43 isoforms upregulated by neuronal hyperactivity drive TDP43 pathology in ALS
Kaitlin Weskamp, Elizabeth M.H. Tank, … Sami J. Barmada·Journal of Clinical InvestigationPeer-reviewed·Nov 12, 2019
- Dysregulated actin dynamics and cofilin correlate with TDP-43 pathology in sporadic amyotrophic lateral sclerosis
Cyril Jones Jagaraj, Prachi M. Mehta, … Julie D. Atkin·bioRxiv·Aug 28, 2023